Derivative exercise or conversion — not an open-market buy.
Loading…
Reporting person on SEC Form 4
Shane Alden Campbell
Shane Alden Campbell is SVP, Proprietary Segment at West Pharmaceutical Services. OQRO lists 8 transactions filed with the SEC under this name, the latest on May 14, 2026, each linked to the official Form 4.
SVP, Proprietary Segment
Disclosures on record
8
Companies involved
1
Disclosure history
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.